Literature DB >> 10364298

Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease.

F Kirchhoff1, P J Easterbrook, N Douglas, M Troop, T C Greenough, J Weber, S Carl, J L Sullivan, R S Daniels.   

Abstract

nef alleles derived from a large number of individuals infected with human immunodeficiency virus type 1 (HIV-1) were analyzed to investigate the frequency of disrupted nef genes and to elucidate whether specific amino acid substitutions in Nef are associated with different stages of disease. We confirm that deletions or gross abnormalities in nef are rarely present. However, a comparison of Nef consensus sequences derived from 41 long-term nonprogressors and from 50 individuals with progressive HIV-1 infection revealed that specific variations are associated with different stages of infection. Five amino acid variations in Nef (T15, N51, H102, L170, and E182) were more frequently observed among nonprogressors, while nine features (an additional N-terminal PxxP motif, A15, R39, T51, T157, C163, N169, Q170, and M182) were more frequently found in progressors. Strong correlations between the frequency of these variations in Nef and both the CD4(+)-cell count and the viral load were observed. Moreover, analysis of sequential samples obtained from two progressors revealed that several variations in Nef, which were more commonly observed in patients with low CD4(+)-T-cell counts, were detected only during or after progression to immunodeficiency. Our results indicate that sequence variations in Nef are associated with different stages of HIV-1 infection and suggest a link between nef gene function and the immune status of the infected individual.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364298      PMCID: PMC112607          DOI: 10.1128/JVI.73.7.5497-5508.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation.

Authors:  L Alexander; Z Du; M Rosenzweig; J U Jung; R C Desrosiers
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  The nef gene from a long-term HIV type 1 nonprogressor.

Authors:  D R Premkumar; X Z Ma; R K Maitra; B K Chakrabarti; J Salkowitz; B Yen-Lieberman; M S Hirsch; H W Kestler
Journal:  AIDS Res Hum Retroviruses       Date:  1996-03-01       Impact factor: 2.205

3.  Research potentials and pitfalls in the use of an HIV clinical database: Chelsea and Westminster Hospital.

Authors:  P J Easterbrook
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

4.  Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity.

Authors:  H M Craig; M W Pandori; J C Guatelli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

5.  Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor.

Authors:  R Salvi; A R Garbuglia; A Di Caro; S Pulciani; F Montella; A Benedetto
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection.

Authors:  R Mariani; F Kirchhoff; T C Greenough; J L Sullivan; R C Desrosiers; J Skowronski
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 7.  HIV-1 Nef and host cell protein kinases.

Authors:  K Saksela
Journal:  Front Biosci       Date:  1997-12-15

8.  Evidence of Nef truncation in human immunodeficiency virus type 2 infection.

Authors:  W M Switzer; S Wiktor; V Soriano; A Silva-Graça; K Mansinho; I M Coulibaly; E Ekpini; A E Greenberg; T M Folks; W Heneine
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

9.  Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity.

Authors:  S Le Gall; M C Prevost; J M Heard; O Schwartz
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

10.  Nef and LTR sequence variation from sequentially derived human immunodeficiency virus type 1 isolates.

Authors:  T McNearney; Z Hornickova; A Templeton; A Birdwell; M Arens; R Markham; A Saah; L Ratner
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

View more
  60 in total

1.  Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope.

Authors:  Eric G Meissner; Karen M Duus; Feng Gao; Xiao-Fang Yu; Lishan Su
Journal:  Virology       Date:  2004-10-10       Impact factor: 3.616

2.  CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.

Authors:  Kristin Agopian; Bangdong L Wei; J Victor Garcia; Dana Gabuzda
Journal:  Virology       Date:  2006-09-18       Impact factor: 3.616

3.  Human Immunodeficiency Virus nef signature sequences are associated with pulmonary hypertension.

Authors:  Sharilyn Almodovar; Rob Knight; Amanda A Allshouse; Sarah Roemer; Catherine Lozupone; Daniel McDonald; Jeremy Widmann; Norbert F Voelkel; Robert J Shelton; Edu B Suarez; Kenneth W Hammer; Cecile Goujard; Nicola Petrosillo; Gerald Simonneau; Priscilla Y Hsue; Marc Humbert; Sonia C Flores
Journal:  AIDS Res Hum Retroviruses       Date:  2012-01-17       Impact factor: 2.205

4.  Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef.

Authors:  Eduardo O'Neill; Lillian S Kuo; John F Krisko; Diana R Tomchick; J Victor Garcia; John L Foster
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Simultaneous assessment of CD4 and MHC-I downregulation by Nef primary isolates in the context of infection.

Authors:  Ayub Ali; Susan Realegeno; Otto O Yang; Martha J Lewis
Journal:  J Virol Methods       Date:  2009-07-28       Impact factor: 2.014

6.  Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1.

Authors:  Art F Y Poon; Luke C Swenson; Winnie W Y Dong; Wenjie Deng; Sergei L Kosakovsky Pond; Zabrina L Brumme; James I Mullins; Douglas D Richman; P Richard Harrigan; Simon D W Frost
Journal:  Mol Biol Evol       Date:  2009-12-02       Impact factor: 16.240

7.  Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.

Authors:  Steffen Wildum; Michael Schindler; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

8.  Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.

Authors:  Michael Schindler; Stephanie Würfl; Philippe Benaroch; Thomas C Greenough; Rod Daniels; Philippa Easterbrook; Matthias Brenner; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  A naturally occurring variation in the proline-rich region does not attenuate human immunodeficiency virus type 1 nef function.

Authors:  Elke Rücker; Jan Münch; Steffen Wildum; Matthias Brenner; Jutta Eisemann; Leonid Margolis; Frank Kirchhoff
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes.

Authors:  Toshiyuki Miura; Mark A Brockman; Chanson J Brumme; Zabrina L Brumme; Jonathan M Carlson; Florencia Pereyra; Alicja Trocha; Marylyn M Addo; Brian L Block; Alissa C Rothchild; Brett M Baker; Theresa Flynn; Arne Schneidewind; Bin Li; Yaoyu E Wang; David Heckerman; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.